Plandai Biotechnology (PLPL) Stock Price, News & Analysis
Company Description
Plandai Biotechnology (OTC Link: PLPL) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $448.9K.
For FY2015, Plandai Biotechnology reported revenue of $93K with net income of -$10.1M. The company operates at a net profit margin of -10842.4%.
This page collects what Stock Titan holds for PLPL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Plandai Biotechnology (PLPL) stock last closed at $0.0000. At a market capitalization of $448.9K, PLPL is classified as a micro-cap stock with approximately 44.9B shares outstanding.
Latest News
Plandai Biotechnology has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 1 with negative movement. Key topics include partnership, acquisition. View all PLPL news →
SEC Filings
Financial Highlights
Plandai Biotechnology generated $93K in revenue in FY2015, operating income reached -$8.8M (-9526.1% operating margin), and net income was -$10.1M, reflecting a -10842.4% net profit margin. The company generated -$2.7M in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
PLPL Company Profile & Sector Positioning
Plandai Biotechnology (PLPL) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.
Investors comparing PLPL often look at related companies in the same sector, including Bcii Enterprises Inc (BCII), Ctr Investments (CIVX), Atlantic Energy (AESO), Plastec Technologies Ltd (PLTYF), and Premier Prods Group Inc (PMPG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PLPL's relative position within its industry.